Editas Medicine, Inc.
CRISPR-CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY
Last updated:
Abstract:
CRISPR/CAS-related compositions and methods for treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
26 Aug 2021
Issue date:
7 Apr 2022